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Abstract
DNA can form several secondary structures besides the classic double helix: one that has
received much attention in recent years is the G-quadruplex (G4). This is a stable four-
stranded structure formed by the stacking of quartets of guanine bases. Recent work has
convincingly shown that G4s can form in vivo as well as in vitro and can affect both replica-
tion and transcription of DNA. They also play important roles at G-rich telomeres. Now, a
spate of exciting reports has begun to reveal roles for G4 structures in virulence processes
in several important microbial pathogens of humans. Interestingly, these come from a range
of kingdoms—bacteria and protozoa as well as viruses—and all facilitate immune evasion
in different ways. In particular, roles for G4s have been posited in the antigenic variation
systems of bacteria and protozoa, as well as in the silencing of at least two major human vi-
ruses, human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV). Although anti-
genic variation and the silencing of latent viruses are quite distinct from one another, both
are routes to immune evasion and the maintenance of chronic infections. Thus, highly dis-
parate pathogens can use G4 motifs to control DNA/RNA dynamics in ways that are rele-
vant to common virulence phenotypes. This review explores the evidence for G4 biology in
such processes across a range of important human pathogens.
What Are G-Quadruplexes andWhy Are They Important?
Over a hundred years ago it was reported that concentrated guanylic acid can self-assemble [1],
but it was not until the 1960s that the structural basis for this phenomenon, the G4, was eluci-
dated [2]. G4s were initially considered a structural curiosity; however, it has since become
clear that they are involved in a number of key biological functions. This has led to the emer-
gence of G4s as a hot topic in nucleic acids research with the vast majority of this research thus
far undertaken in highly tractable model systems such as Saccharomyces cerevisiae or human
cell lines. However, there is now a rapidly developing literature on the roles of G4s in human
pathogens. This review will briefly outline the known roles for G4s in the cell biology of model
systems, and then explore how these can map onto pathogen biology, particularly to facilitate
immune evasion.
In terms of structure, the basic unit of the G4 is the G-tetrad, a planar array of four Hoogs-
teen-bonded guanine bases, which when stabilised by monovalent cations, stack on top of one
another to form the G4 structure itself (Fig. 1). The stacked G-tetrads are connected by loops
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formed from intervening mixed-sequence nucleotides: these loops vary in both size and se-
quence from one G4 to another. The four strands comprising the G4 may originate from one,
two, or four separate strands of DNA or RNA. G4s can therefore be described as either intra-
molecular or intermolecular (Fig. 1C, D). In addition, there is directionality to the strands,
which can be described as running from the 50 end to the 30 end. G4s can therefore exist as a
number of topological variants (Fig. 1C, D). The conformation of glycosidic bonds of guanine
bases in G-tetrads, the cations present and the number of stacked G-tetrads further contribute
to the myriad of topologies found amongst G4s [3–6].
Predictive algorithms, such as G4P Calculator [7] and QuadParser [8], have been developed
to identify putative quadruplex sequences (PQS) within nucleic acid sequences. Use of these al-
gorithms in whole genome sequences has revealed that PQS are not randomly located through-
out genomes but are overrepresented in gene regulatory regions and repetitive regions such as
telomeres [9,10]. RNA G4s are present in transcripts associated with telomeres, in noncoding
regions of primary transcripts, and also in mature transcripts.
Fig 1. G-quadruplex (G4) structure. (A) A putative quadruplex sequence (PQS) is a nucleotide sequence predicted to form a G4 structure. A degenerate
PQS used to predict the formation of intramolecular G4s is shown here, consisting of four runs of at least three guanines per run, separated by short stretches
of other bases (N). (B) The basic unit of the G4 is the G-tetrad. (C) G4 structures display a large variety of different topologies. Topology of intramolecular G4
structures displaying antiparallel (left) and parallel (right) configurations. (D) Topology of intermolecular G4 structures formed by dimerisation of four strands
(left) or two strands (right).
doi:10.1371/journal.ppat.1004562.g001
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The regions in which PQS occur are linked to the specific functions of G4s at these loca-
tions. For example, at telomeres, G4 structures are proposed to be involved in telomere mainte-
nance at both the RNA and DNA level. Eukaryotic telomeric DNA consists of long stretches of
tandemly repeated G-rich sequences, such as GGGTTA in humans, which end in a 30 single-
stranded DNA overhang. A protein complex caps these overhangs in order to prevent them
being identified by cellular surveillance mechanisms as unwanted DNA breaks. These G-rich
telomeric repeats can form G4s both in vitro and in vivo and can protect telomeres: in S. cerevi-
siae telomeric G4s may provide an alternative form of telomere capping when natural capping
is compromised [11]. In addition, telomeric G4s protect the telomeric 30-overhang from being
recognised by telomerase, thereby regulating telomerase activity. Human telomeres are tran-
scribed to produce long, noncoding telomeric repeat-containing RNAs (TERRAs), which con-
sist of UUAGGG repeats and adopt a G4 RNA structure [12,13]. TERRAs interact with the
telomere binding protein TRF2 to promote telomere heterochromatinisation [14,15].
In promoter regions, the dynamic behaviour of G4s may be directly involved in gene regula-
tion at the level of transcription. One of the best studied systems for a role of G4s in transcrip-
tional regulation is the human c-MYC locus. c-MYC is a transcription factor whose expression
is linked to cell proliferation and tumourigenesis. Nuclease hypersensitive element III (NHE
III1), a major regulator of c-MYC transcription, contains a PQS that forms a G4 structure in
vitro [16]. A gene containing wild-type NHE III1 is less expressed than one containing a mutat-
ed version that cannot form a G4 structure, so the PQS in NHE III1 represses transcription
[17]. Additionally TMPyP4, a G4-stabilising ligand, reduces c-MYC expression in lymphoma
cell lines [17].
Where G4s occur in gene bodies, they can form steric road blocks to the DNA transcription-
al machinery, and certain helicases, such as those of the RecQ and Pif1 families, possess G4-re-
solving activity to aid transcription through these four-stranded snags. Disruption of G4-
resolving helicases in Caenorhabditis elegans [18], S. cerevisiae [19] or human cells lines [20]
results in genetic instability, and G4s are a hallmark of fragile sites in the human genome [21].
In RNA transcripts, G4s may play roles in pre-mRNA processing, translation and
RNA turnover.
Given their propensity to induce genomic instability and DNA damage, it is hypothesised
that G4s could be used alongside inhibitors of DNA repair or associated pathways to inhibit
tumourigenesis. For example, the G4-interactive compound Quarfloxin (CX-3543, Cylene
Pharmaceuticals) is a first-in-class drug that progressed to Phase II clinical trials for cancer.
Quarfloxin selectively disrupts the interaction of ribosomal DNA G4s with nucleolin, thereby
inhibiting RNA polymerase I and inducing apoptosis in cancer cells [22]. Furthermore, stabili-
sation of G4s may be an effective approach by which to inhibit telomerase activity in tumour
cells [23]. The field of G4 biology, so far largely motivated by this potential for developing
novel anti-cancer therapeutics, has provided us with both a conceptual basis and a molecular
toolset (Box 1) with which to approach the burgeoning field of pathogen G4 biology.
Roles for G4s in Recombination-Mediated Antigenic Variation
Antigenic variation (Av) is the process by which pathogens express different versions of their
surface epitopes in order to evade detection by the host immune system. In general, the patho-
gen possesses a bank of genes encoding possible antigenic variants but expresses only one of
these genes at any time. Switching can be mediated by a variety of sophisticated genetic and
epigenetic systems, but in several well-characterised pathogens—including Neisseria gonor-
rhoeae, the bacterium responsible for gonorrhoea, and Trypanosoma brucei, the causative
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Box 1. The G4 Biology Toolbox
Many tools have been developed to analyse G4s at both genome-wide and sequence-
specific levels.
Predictive algorithms
Intramolecular G4s form from short runs of guanine bases separated by short runs of
other bases. Intermolecular G4 structures form from G-runs on two or more nucleic acid
strands. Therefore, by searching for sequences matching these criteria, we can identify
genomic regions that may form G4s, termed putative quadruplex sequences (PQS) or G4
motifs. Predictive algorithms (reviewed in [70]), including quadparser [8], G4P calcula-
tor [7], QGRS mapper [71] and QuadBase [72], have been developed to identify PQS.
These algorithms can rapidly analyse large amounts of data, including whole
genome sequences.
Biophysical techniques
Several experimental techniques can determine whether the biophysical features of a syn-
thetic PQS-containing oligonucleotide are consistent with G4 structure formation. These
include dimethylsulfate footprinting, thermal denaturation, ultraviolet spectroscopy and
circular dichroism spectroscopy. Complete structure determination necessitates the use
of X-ray crystallography or nuclear magnetic resonance structure determination.
G4-interactive compounds
Diverse families of small molecules preferentially bind to G4 DNA over other types of
DNA. These include the fluoroquinolone quarfloxin [22], the acridine derivative
BRACO19 [73], telomestatin [74], and triazines [75], among many others (reviewed in
[4]). Compounds that stabilise and/or induce G4 formation can be used to investigate
the biological roles of G4s. In addition, the RNA G4-selective ligand carboxyPDS has re-
cently been described [69].
G4 structure-specific antibodies
G4-structure specific antibodies have been exploited to visualise G4s in both genomic
DNA and cytoplasmic RNA. High-affinity single-chain antibodies, generated by ribo-
some display, have been used to visualise G4s at the telomeres of the ciliate Stylonychia
lemnae [76,77]. More recently, a monoclonal single-chain antibody generated by phage
display has been used to visualise G4s in the genomic DNA and cytoplasmic RNA of a
range of mammalian cells [68,69].
G4-interacting proteins
Many proteins have been identified which interact physically and/or functionally with
G4s in a variety of organisms. Some G4-interacting proteins, such as the β subunit of the
Oxytricha nova telomere-binding protein, promote the formation of G4s from PQS
[78,79]. The binding of some proteins to extant G4s increases the stability of the G4
structure [80,81]. Conversely, a group of G4 destabilising proteins has been discovered.
These include the highly conserved human telomeric protein POT1 [82] and a number
of single-strand binding proteins of the heterogenous nuclear ribonucleoprotein
(hnRNP) family [83–85]. In addition a number of helicases preferentially bind and dis-
rupt DNA G4s. Experimentally modulating the expression or stability of these proteins
offers a means by which to perturb G4 stability.
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agent of sleeping sickness—it is genetic recombination into a single gene expression site that
mediates antigenic switching.
G4s have now been implicated in Av in several pathogens, the best characterized example
being N. gonorrhoeae, which uses a G4-mediated system to switch the expression of its cell-sur-
face pilin proteins (Fig. 2). During pilin antigenic variation, only the pilin gene residing at the
active pilE locus is expressed and the resident gene is frequently replaced with a gene from a
pool of silent pilS loci. The recombination initiation site has been mapped to a 16 base pair
(bp) G-rich segment that forms a parallel intramolecular G4 structure in vitro and is located
upstream of the pilE locus [24]. Disruption of this structure through site-directed mutagenesis
prevented the formation of single-stranded nicks that can initiate recombination, and thus sup-
pressed pilin Av [24]. Furthermore, recombinant RecA specifically bound to the pilE G4 to
stimulate strand exchange in vitro, suggesting that the G4 structure may recruit recombination
factors to the pilE locus [25]. Finally, mutation of the N. gonorrhoeae RecQ helicase (a struc-
ture-specific helicase which can unwind the pilE G4 structure in vitro) resulted in defective
pilin Av [26].
Fig 2. Schematic model of the role of the pilEG-quadruplex (G4) inN. gonorrhoeae pilin antigenic
variation. A putative quadruplex sequence (PQS) and a small RNA (sRNA) promoter are located upstream
of the pilE locus (A). The initiation of transcription from the sRNA promoter (B) provides the single-stranded
conditions required for G4 formation (C). The pilEG4 recruits RecA (D) and potentially other recombination
factors, which stimulates non-reciprocal recombination between a pilS locus and the pilE locus (E).
doi:10.1371/journal.ppat.1004562.g002
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A long-standing question in the field of G4 biology has been whether these structures actu-
ally form and persist in vivo from the inherently stable DNA double helix. For this to occur, G4
structure formation must be preceded or accompanied by localised unwinding of the double
helix. Active transcription results in the spread of negative superhelicity behind the transcrip-
tional machinery [27,28], and this can provide the torsional stress required for unwinding of
the double helix and the formation of G4s [29]. At the pilE locus, active transcription of a small
noncoding RNA (sRNA), which initiates within the pilE G4-forming sequence, is required for
pilin Av (Fig. 2B). The expression of this sRNA in trans cannot complement a loss-of-function
mutant in the sRNA promoter, implying that active in situ transcription may be providing the
torsional stress required for helix unwinding and G4-structure formation [30].
It is interesting to speculate on whether this well-characterised system for promoting re-
combinational Av can be generalized to other pathogens. A recent analysis of>600 Neisseria
meningitidis isolates found PQS adjacent to some, but not all, pilE gene sequences; specifically,
they were found 50 or 30 of class I, but not class II, pilE loci. [31]. Given that the former, and not
the latter, are antigenically unstable, we speculate that G4s may also play a role in N.meningiti-
dis class I pilin Av.
An entirely different genus of pathogenic bacteria also evades the host immune response
through Av: these are the spirochetes Borrelia spp., some of which cause human Lyme disease.
Lyme spirochetes evade the host immune response through gene conversion-driven Av of a
surface lipoprotein, Vmp-like sequence E (VlsE). Runs of guanines capable of forming inter-
molecular G4 structures in vitro are abundant on the coding strand of the vls locus in several
Lyme Borrelia strains and species [32]. It is not yet known whether G4s actually form in vivo at
this locus to play an active role in promoting gene conversion. In vitro, however, Borrelia telo-
mere resolvase does appear to disrupt intermolecular G4s formed from this locus [33]. This en-
zyme has single-strand annealing and strand exchange activities, both of which have been
hypothesised to play roles in gene conversion at the vlsE locus.
Further understanding of the initiating events of antigenic switching in this system will help
to determine what, if any, role G4s play in Lyme Borrelia Av and recombinational switching.
More generally, genome-wide scans for the distribution of PQS within bacterial genomes sug-
gest that G4s are widely distributed and may actually have quite broad roles in the regulation
of bacterial genes. G4s may therefore affect virulence processes in many more bacterial patho-
gens, and tractable bacterial species that contain G4s, like Escherichia coli, could prove useful
models for future studies [34,35]. Finally, this model may also apply in eukaryotic as well as
prokaryotic microbes, since there is an unexplored role for G4s in the antigenic switching of
variant surface glycoproteins in T. brucei, where G-rich telomeres—potential G4-forming sites
—facilitate the switching of VSG virulence genes [36].
Other Roles for G4s in Antigenic Variation
It is clear that G4 motifs have key roles in certain recombination-mediated Av systems. There
are, however, other systems of Av that are mechanistically distinct, such as that mediated by
epigenetic silencing in the fungal pathogen Candida glabrata [37] and the protozoan malaria
parasite Plasmodium falciparum [38]. Could G4s play a role here too? Although this area re-
mains underexplored, bioinformatic work on P. falciparum suggests that indeed they could. A
search of the P. falciparum genome for G4 motifs revealed that outside of the telomeres, PQS
are rare in this AT-rich genome [39]. Interestingly, half of the non-telomeric PQS are located
in or upstream of a large, multicopy, hypervariable gene family called var [39]. Var genes en-
code P. falciparum erythrocyte membrane protein 1 (PfEMP1), a family of variant immunodo-
minant surface antigens, which are important virulence factors [40–42]. Var gene expression is
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mutually exclusive and P. falciparum frequently switches to express different var genes. Fur-
thermore, var genes regularly recombine to generate new variants. Transcriptional switching is
mediated by epigenetic silencing of all but one var locus and switching occurs when the current
active site becomes heterochromatic while another site becomes euchromatic and actively tran-
scribed—the trigger for this is still unknown [43].
The predominance of G4 motifs in var gene regulatory regions suggests that they may play
roles in var gene recombination and/or switching. G4 motifs upstream of well-characterised
genes in model systems can alter levels of transcription, e.g., in the c-MYC oncogene [17], and
changes to G4 metabolism can also induce switches in epigenetic silencing [44–46]. Plasmodi-
um possesses at least some of the enzymes known to metabolise G4s: P. falciparum contains
two putative RecQ helicases [47], although there is no recognizable Pif1. It is also notable that
most of the var family (like several other variantly-expressed gene families in this parasite) is
located just inside the telomeres, raising the possibility that telomeric G4s may play roles in
both telomere maintenance and the regulation of subtelomeric virulence gene families. Syn-
thetic oligonucleotides composed of the degenerate P. falciparum telomeric motif GGGTTYA
are indeed able to form stable G4 structures in vitro [48], although their biological significance
awaits confirmation in vivo.
Could G4s Play a Role in Viral Latency?
Recent research suggests that viruses may use G4s as cis-acting regulatory elements in gene ex-
pression. The retroviral HIV-1 genome contains two copies of single-stranded RNA encoding
nine genes. Following infection, the RNA is transcribed by reverse transcriptase into double-
stranded DNA, which is integrated into the infected cell genome. The HIV-1 long terminal
repeat (LTR) controls viral transcription within the integrated provirus and contains two intra-
molecular G4s within a 57 bp G-rich tract of its U3 promoter region [49]. This tract contains
five cellular transcription factor binding sites: two NF-κB and three Sp1 (Fig. 3A). When the
wild-type LTR sequence was placed upstream of a luciferase reporter, G4-disrupting mutations
or the addition of a G4-stabilising ligand resulted in increased and decreased promoter activity,
respectively, suggesting that G4s may regulate HIV-1 LTR promoter activity [49].
Fig 3. Schematic representation of the mechanisms by which G-quadruplexes (G4) may contribute to the maintenance of viral latency. (A) In the
integrated HIV-1 provirus, the U3 region contains two NF-κΒ binding sites (black blocks) and three Sp1 binding sites (grey blocks). Here, the formation of a
G4 from the G-rich Sp1 binding sites is shown, but several distinct G4s can form in this region. G4 formation inhibits transcription from the transcription start
site (TSS). This transcriptional repression may be mediated by the differential affinity of transcription factors for double-stranded and G4 DNA. (B) The
glycine-alanine repeat domain of Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) mRNA contains PQS. G4 formation inhibits translation, thereby
reducing EBNA1 protein levels and limiting the presentation of EBNA1 peptides by antigen presenting cells (APC) via the major histocompatibility complex
(MHC) pathway.
doi:10.1371/journal.ppat.1004562.g003
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There is further evidence that the U3 promoter region may be capable of dynamically
adopting various G4 structures with the potential to bind cellular transcription factors. In addi-
tion to the two parallel-like intramolecular G4s described above, Amrane and colleagues found
that a synthetic sequence derived from the same promoter region could form a hybrid G4
structure consisting of a two-G-tetrad antiparallel G4 with a further Watson-Crick CG bp [50].
Furthermore, Piekna-Przybylska et al. found that synthetic oligonucleotides comprising G-
runs from the three Sp1 binding sites could adopt a variety of configurations in vitro, including
parallel, antiparallel and hybrid G4 conformations [51]. Pull-down assays indicated that Sp1
could bind to one of the Sp1 sites folded into a G4 structure [51]. Given that Sp1 activity is as-
sociated with the maintenance of viral latency [52,53] and G4 structures within the U3 promot-
er region can suppress transcriptional activity [49], this potential for alternate protein-DNA
interactions may play a role in HIV-1 latency [51].
G4s may also play a role in the transcriptional regulation of the HIV-1 provirus itself. Three
adjacent, highly conserved PQS, capable of forming stable G4 structures in vitro, are located
within the proviral nef gene. When the nef gene was cloned upstream of the reporter gene
green fluorescent protein (GFP), the addition of a G4-stabilising drug, but not of its non-G4
binding analogue, reduced GFP expression levels [54]. This G4-mediated transcriptional regu-
lation may have important implications for viral pathogenicity as the HIV-1 Nef protein is an
important virulence factor [55]. Finally, stable G4 structures can form in regions of the HIV-1
RNA genome [51,56], where they may be involved in regulating reverse transcription of
the genome.
Moving from HIV-1 to EBV, very recent evidence suggests that G4s may also play a role in
the latency program of this gammaherpesvirus. Here, however, the G4 acts at the level of RNA
translation rather than DNA transcription. Following infection, down-regulation of viral pro-
tein synthesis relies heavily upon a class of viral proteins that can inhibit their own synthesis,
termed “genome maintenance proteins.” The mRNA for one of these genome maintenance
proteins, EBV-encoded nuclear antigen 1 (EBNA1), contains G4 structures within its glycine-
alanine repeat domain (GAr)-encoding region. These may regulate its translation, since dis-
ruption of these G4 structures reduces ribosome dissociation and increases EBNA1 mRNA
translation (Fig. 3B) [57]. Furthermore, destabilisation of these G4 structures, following trans-
fection of a vector expressing native GAr mRNA fused to a sequence encoding an ovalbumin
epitope, resulted in enhanced antigen presentation of that epitope by a T-cell hybridoma [57].
These results have been mimicked with the EBNA1 antigen itself in an in vivo mouse model,
where EBNA1 mRNA G4 destabilisation resulted in enhanced antigen presentation by dendrit-
ic cells and the early priming of CD8+ T cells [58], demonstrating that reducing the translation
efficiency of viral proteins is a key part of the latency program of this gammaherpesviruses.
Finally, G-rich regions from both control and coding regions of some human papillomavi-
rus (HPV) genomes are able to form G4 structures and may also carry out regulatory functions
in this virus [59]. The roles of G4s in the silencing of at least two major human viruses provide
them with a flexible tool with which to evade immune detection and thereby maintain chronic
infections. Thus, although the mechanisms are entirely distinct, the results in terms of viru-
lence are comparable to those of the Av systems described above.
Roles for G4s in Antigenic Diversification
G4 motifs have been proposed to play roles not only in antigenic switching but also in the gen-
eration of antigenic diversity. So what are the molecular mechanisms by which these structures
might induce recombination or mutation, and thus diversification of PQS-containing antigen-
encoding genes? Recent research, using S. cerevisiae as a tractable tool with which to investigate
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G4 dynamics, has unearthed some possible mechanisms. Particularly informative is a reporter
assay developed by the Nicolas laboratory that determines the frequency of size variants of the
human G4-forming CEB1 minisatellite when inserted into a yeast chromosome. This work has
established that it is replication fork stalling at unresolved G4s that leads to recombination and
contraction or expansion of CEB1 repeats, and this is highly dependent on the Pif1 enzyme, an
evolutionarily conserved helicase recently recognized to be a highly-efficient G4 helicase [19].
Interestingly, replication-dependent instability of G4 motifs was affected by the direction of
the replication fork; it occurred only when the G4 was in the leading-strand template. The per-
sistence of G4 structures on the leading-strand template led to Rad51/Rad52-dependent repair
mechanisms, generating characteristic recombination intermediates and resulting in deletions
at CEB1 repeats [60]. Determining the molecular detail of G4-dependent DNA transactions at
such exquisite resolution may only be possible in a model organism like S. cerevisiae, but such
work provides a model of how failure to resolve G4 structures can lead to error-prone recombi-
national repair that may result in the diversification of antigenic repertoires such as those en-
coded by vars or vsgs.
Elegant work in yeast has also provided clues about the possible role of G4s in Av occurring
via epigenetic transcriptional switching. Paeschke et al. have showed that unresolved G4s can
lead to changes in the epigenetic state of adjacent chromatin [46]. They introduced Pif1-bind-
ing G4 motifs into a nonessential arm of the yeast chromosome containing two selectable
markers and assayed for gross chromosomal rearrangements or deletions (the term “deletion”
normally refers to the loss of both markers, and is in contrast to a point mutation, which would
affect only one marker). In wild-type strains, the rare loss of resistance to the selective agents
did indeed result from loss of the whole chromosomal region. In Pif1-deficient strains, howev-
er, loss of resistance occurred much more frequently, and appeared to occur via epigenetic si-
lencing: the sequences and positions of the selectable markers remained unchanged and their
expression could be restored through deletion of SIR2, a histone-modifying deacetylase enzyme
that is known to enforce epigenetic silencing. Thus, failure of G4 structures to be resolved re-
sulted in epigenetic modifications near the G4 motifs. This may be because DNA synthesis be-
comes uncoupled from histone recycling mechanisms, leading to dysregulation of epigenetic
status [44].
The high recombination rate of the HIV-1 provirus allows the virus to delay immune recog-
nition and clearance, and G4 metabolism may be at play here too. Recombination hot spots
and PQS have been found to correlate in the U3 promoter [51], gag [61] and cPPT [62] regions
of the HIV-1 RNA genome, suggesting that G4s may contribute to this high mutation rate by
enabling RT template switching during reverse transcription.
Perspectives
G4 motifs offer disparate pathogens—from bacteria, to protozoa, to viruses (Fig. 4 and Table 1)
—a means by which to regulate DNA and/or RNA dynamics underlying the common virulence
phenotypes of antigenic variation and viral latency. Understanding the G4-mediated regulation
of pathogen virulence may open the door to novel therapeutic interventions. Similar to anti-
cancer strategies targeting G4s in telomeres and oncogenes, a pathogen’s RNA or DNA could
be targeted by G4-specific ligands, and the high topological variety amongst G4 structures sug-
gests that a high level of drug specificity could be achieved [63]. Indeed, the G4-stabilising li-
gand BRACO-19 is able to inhibit HIV-1 infectivity [49,56] and block the proliferation of
EBV-positive cells in vitro [64].
The wide range of pathogens using G4s in regulatory processes suggests that G4s may regu-
late similar processes in other pathogens. For example, in addition to Neisseria and Borrelia
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there are a number of other prokaryotic and eukaryotic pathogens that use controlled DNA-re-
combination-associated Av systems. Investigation of G4 dynamics in these pathogens, which
include, among others, species ofMycoplasma [65], Trypanosoma [66] and Babesia [67],
Fig 4. Phylogenetic tree schematic displaying the evolutionary relationships among the pathogens
discussed in this review. The model systems S. cerevisiae and E. coli are also shown. Branches are not
proportional to evolutionary distance.
doi:10.1371/journal.ppat.1004562.g004
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would merit an interesting line of investigation. Amongst viruses, the PQS found in the U3
promoter region of the HIV-1 proviral genome were found to be conserved in HIV-2 and simi-
an immunodeficiency virus [51], indicating that G4s may affect the latency program of these
viral species. Furthermore, in addition to EBV EBNA1 mRNA, PQS are present in the mRNA
of a number of other gammaherpesviral genome maintenance proteins [57], which may also
therefore be subject to G4-mediated translational control.
A highly G4-specific monoclonal antibody generated by phage display has recently been
used to demonstrate the presence of G4s in the genomic DNA and cytoplasmic RNA of a range
of human cells [68,69]. This antibody, or others similarly developed, could provide a useful
tool with which to investigate pathogen G4 dynamics. Finally, it is worth noting that research
on pathogen G4 dynamics is relevant to those pursuing G4s as anticancer targets. A number of
cancers are associated with HPV and gammaherpesviruses such as EBV; therefore the develop-
ment of new therapeutic targets based on G4s in these viruses also has the potential to reduce
the burden of these malignancies.
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